Nieves, E. E., Cimino, R. O., Krolewiecki, A. J., Juarez, M., Lanusse, C. E., Alvarez, L. I., & Ceballos, L. (2024). Albendazole metabolites excretion in human saliva as a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs. Web
Citación estilo ChicagoNieves, Elvia Ester, Rubén Oscar Cimino, Alejandro Javier Krolewiecki, Marisa Juarez, Carlos Edmundo Lanusse, Luis Ignacio Alvarez, and Laura Ceballos. Albendazole Metabolites Excretion in Human Saliva As a Biomarker to Assess Treatment Compliance in Mass Drug Administration (MDA) Anthelmintic Programs. 2024.
Cita MLANieves, Elvia Ester, et al. Albendazole Metabolites Excretion in Human Saliva As a Biomarker to Assess Treatment Compliance in Mass Drug Administration (MDA) Anthelmintic Programs. 2024.